Evidence map›Paper›PMID 32849597›Full record

ArticleFrontiers in immunology2020

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV.

Maaike Nederend, Arthur H van Stigt, J H Marco Jansen, Shamir R Jacobino, Sylvia Brugman, Cornelis A M de Haan, Louis J Bont, R J Joost van Neerven, Jeanette H W Leusen

Open access · goldAbstract readComparative Study
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The contribution of bovines to human health against viral infections.Environmental science and pollution research international · 2021
    Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Maaike NederendCenter for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Arthur H van StigtCenter for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
J H Marco JansenCenter for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Shamir R JacobinoCenter for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Sylvia BrugmanAnimal Sciences Group, Department of Cell Biology and Immunology, Wageningen University and Research, Wageningen, Netherlands.
Cornelis A M de HaanVirology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
Louis J BontCenter for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
R J Joost van NeervenFrieslandCampina, Amersfoort, Netherlands.
Jeanette H W LeusenCenter for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
University Medical Center Utrecht · NLWageningen University & Research · NLUtrecht University · NLWilhelmina Children's Hospital · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) infections represent a major burden of disease in infants and are the second most prevalent cause of death worldwide. Human milk immunoglobulins provide protection against RSV. However, many infants depend on processed bovine milk-based nutrition, which lacks intact immunoglobulins. We investigated the potential of bovine antibodies to neutralize human RSV and facilitate-cell immune activation. We show cow's milk IgG (bIgG) and Intravenous Immunoglobulin (IVIG) have a similar RSV neutralization capacity, even though bIgG has a lower pre-F to post-F binding ratio compared to human IVIG, with the majority of bIgG binding to pre-F. RSV is better neutralized with human IVIG. Consequently, we enriched RSV specific T cells by culturing human PBMC with a mixture of RSV peptides, and used these T cells to study the effect of bIgG and IVIG on the activation of pre-F-pecific T cells. bIgG facilitated

Indexed as

AnimalsAntigens, ViralAntiviral AgentsCattleCell LineColostrumDisease Models, AnimalEpitopesFemaleHost-Pathogen InteractionsHumansImmunoglobulin GImmunoglobulins, IntravenousLymphocyte ActivationMice, Inbred C57BLMice, KnockoutAntigens, ViralAntiviral AgentsEpitopesImmunoglobulin GImmunoglobulins, IntravenousReceptors, IgGbovine IgGimmunoglobulinprophylaxisRSVT cell activation

Identifiers

PMID32849597
PMCPMC7423966
OpenAlexW3048219171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.